Cargando…
Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
BACKGROUND/AIM: Evidence shows that Luminal A breast cancer is likely to undergo bone metastasis, but the mechanisms involved remain unknown. This study’s aim was to demonstrate a correlation between estrogen receptor (ER) positivity and bone metastasis as the clinically preferred site of metastasis...
Autores principales: | Chiu, Jen-Hwey, Wen, Che-Sheng, Wang, Jir-You, Hsu, Chih-Yi, Tsai, Yi-Fang, Hung, Shih-Chieh, Tseng, Ling-Ming, Shyr, Yi-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418839/ https://www.ncbi.nlm.nih.gov/pubmed/28472954 http://dx.doi.org/10.1186/s12967-017-1192-x |
Ejemplares similares
-
Molecular characteristics of recurrent triple-negative breast cancer
por: TSAI, CHUNG-HSIN, et al.
Publicado: (2015) -
Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer
por: Tsai, Yi-Fang, et al.
Publicado: (2017) -
Timosaponin AIII Suppresses Hepatocyte Growth Factor-Induced Invasive Activity through Sustained ERK Activation in Breast Cancer MDA-MB-231 Cells
por: Tsai, Chung-Hsin, et al.
Publicado: (2013) -
Estrogen and G protein-coupled estrogen receptor agonist G-1 cause relaxation of human gallbladder
por: Lee, Ming-Che, et al.
Publicado: (2016) -
Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor‐positive breast cancer via regulation of the mTOR pathway
por: Hsu, Hui‐Ping, et al.
Publicado: (2022)